Site hosted by Angelfire.com: Build your free website today!

 

VACCINATION

 

Immunization is in preventive medicine process of rendering people immune to an infectious organism by inoculating them with a form of the organism that doesn’t cause severe disease, but does provoke formation of protective antibodies. The process has also been called vaccination, because the first instance of immunization was the use of vaccinia or cowpox, virus to produce immunity to variola or smallpox. Vaccines are the most effective protection against most diseases caused by viruses and related organisms, because few antibiotics work against them. In Western countries vaccines are routinely used in the first years of life to produce immunity to diptheria, tetanus, poliomyelitis, Haemophilus influenza type B and whooping cough.

 

A vaccine may contain: organisms killed by exposure to heat or chemicals (the first polio vaccine, and one for typhoid fever); an inactivated form of a toxin, produced by the organism and called a toxoid (tetanus and diphtheria vaccines); or a live “attenuated” virus—one grown in such a way that it can no longer cause serious disease (the polio vaccine developed by Albert Sabin and vaccines against measles and yellow fever).

 

The first modern use of immunization was by the British doctor Edward Jenner in 1796, when he used cowpox inoculations to produce protection against smallpox. In 1885 the French scientist Louis Pasteur first used an attenuated rabies virus to protect against the natural infection and in 1897 a vaccine against typhoid fever was developed in England.

 

The immunizing substance is usually introduced through a scrape in the skin, called inoculation, although the Sabin polio vaccine is taken orally. Protection lasts for varying periods: the plague vaccine for only six months; the yellow fever vaccine for ten years.

 

A population can be immunized in two ways. In one method, the vaccine is targeted at those most likely to get the disease. In the recent successful campaign to eradicate smallpox worldwide, a form of this strategy was used. Most diseases in Western countries, on the other hand, are controlled through the principle of herd immunity, in which it is held that the transmission of disease will be stopped when an extremely low probability exists that an infected person will come into contact with an unprotected individual. Not every person needs to be immunized, but protection levels of 90 per cent must be reached for some diseases. In some instances a combined strategy is used. For rubella, or German measles, for example, public health workers aim at mass immunization of school-age children as well as of women of childbearing age.

New vaccines are still being developed, such as a safer, less painful vaccine against rabies and vaccines against hepatitis B and pneumonia-causing bacteria. Diseases common in the developing world for which vaccines are being sought include cholera and parasitic infections such as malaria and trypanosomiasis (sleeping sickness). In addition to active immunization (stimulating antibody formation by introducing a form of the infectious organism), protection may also be provided by passive immunization (injecting serum containing antibodies, usually obtained from a person who has recently had the disease). The latter procedure is now seldom used, except in some cases of hepatitis.

 

                

       Rudolf Weigl 1883 – 1957                   Thomas Weller 1915     “ Now protect with vaccination against influenza ! ”

discovered Typhus vaccination        discovered Rubella vaccination                      German slogan

 

 

Edward Jenner 1749 – 1823

British doctor, who discovered the vaccine that is used against smallpox and who laid the groundwork for the science of immunology. Born on May 17, 1749, in Berkeley, Gloucestershire, in a rural vicarage, Jenner became a keen observer of nature at an early age. After nine years as a surgeon's apprentice, he went to London to study anatomy and surgery under the prominent surgeon John Hunter, then returned to Berkeley to start a country practice that lasted the rest of his life.

 

Smallpox, a major cause of death in the 18th century, was treated in Jenner's time by the often-fatal procedure of inoculating healthy persons with pustule substances from those who had mild cases of the disease. Jenner observed, among his patients, that those who had been exposed to the much milder disease cowpox were completely resistant to these inoculations. In 1796 he inoculated an eight-year-old boy with cowpox virus; six weeks after the boy's reaction Jenner reinoculated him with smallpox virus, finding the result negative. By 1798, having added similarly successful cases, Jenner wrote An Inquiry into the Causes and Effects of the Variolae Vaccinae, a Disease Known by the Name of Cow Pox, a tract in which he also introduced the term virus.

 

Jenner encountered some public resistance and professional chicanery in publicizing his findings, and he experienced difficulties in obtaining and preserving cowpox vaccine. Nevertheless, his procedure was soon accepted, and mortality due to smallpox plunged. The procedure quickly spread through Europe and to North America. Three-quarters of a century later, the French chemist Louis Pasteur, drawing on Jenner's work, set a course for the science of immunology and the discovery of modern preventive vaccines. Jenner died in Berkeley on January 26, 1823.

 

 

Jonas Edward salk 1914 – 1995

American doctor and epidemiologist, who developed the first vaccine against poliomyelitis. Salk's work in the 1940’s on an antiinfluenza vaccine led him and his colleagues to develop an inactivated vaccine against polio in 1952. After successful wide-scale testing in 1954, the vaccine was distributed nationally and greatly reduced the disease. In the mid-1950’s the American virologist Albert Sabin developed an attenuated (live) oral vaccine, which with Salk's discovery brought polio under control

 

 

Albert Bruce sabin 1906 – 1993

Polish-born American virologist, who developed an oral, live-virus poliomyelitis vaccine. Born in Bialystok, Sabin emigrated with his parents to the United States in 1921 and received an MD degree from New York University in 1931. After working at the Rockefeller Institute, he joined the staff of the Children's Hospital Research Foundation and the College of Medicine of the University of Cincinnati. Sabin spent many years in search of protective vaccines against the strains of polio viruses that had been killing or severely crippling many children, especially during epidemics from 1942 to 1953. In the mid-1950’s he developed a polio virus strain that did not cause paralysis of the central nervous system in animals. Sabin's vaccine was attenuated and live, in contrast to the inactivated, injected virus developed by the American doctor and epidemiologist Jonas Salk. The vaccine passed tests for which Sabin and others volunteered, and then successfully passed worldwide large-scale field tests from 1958 to 1960. After 1961 Sabin concentrated on studying the role of viruses in cancer.